StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Panacea Life Sciences's revenue for the twelve months ending Mar 31, 2024 was $2.76M, up 50.4% year over year. For fiscal 2023 it was $2.38M, up 46.6% from the year before. The highest annual figure on record is $9.02M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$2.38M+46.6%
FY2022Dec 31, 2022$1.63M-21.0%
FY2021Dec 31, 2021$2.06M-77.2%
FY2020Dec 31, 2020$9.02M+2508.7%
FY2019Dec 31, 2019$345.68K–
FY2018Dec 31, 2018$0–
FY2017Dec 31, 2017$0–
FY2016Dec 31, 2016$0-100.0%
FY2015Dec 31, 2015$213-75.0%
FY2014Dec 31, 2014$852–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024$1.06M+55.9%
Q4 FY2023Dec 31, 2023$960.50K+195.7%
Q3 FY2023Sep 30, 2023$347.85K-5.0%
Q2 FY2023Jun 30, 2023$399.13K-15.0%
Q1 FY2023Mar 31, 2023$677.48K+45.2%
Q4 FY2022Dec 31, 2022$324.79K-49.7%
Q3 FY2022Sep 30, 2022$366.24K-37.7%
Q2 FY2022Jun 30, 2022$469.47K+49.8%
Q1 FY2022Mar 31, 2022$466.47K-8.9%
Q4 FY2021Dec 31, 2021$645.95K-9.3%
Q3 FY2021Sep 30, 2021$588.04K-56.2%
Q2 FY2021Jun 30, 2021$313.50K-94.9%
Q1 FY2021Mar 31, 2021$512.14K-38.7%
Q4 FY2020Dec 31, 2020$712.09K+448.3%
Q3 FY2020Sep 30, 2020$1.34M+2133.7%
Q2 FY2020Jun 30, 2020$6.16M+10143.0%
Q1 FY2020Mar 31, 2020$836.00K+5131.5%
Q4 FY2019Dec 31, 2019$129.86K–
Q3 FY2019Sep 30, 2019$60.15K–
Q2 FY2019Jun 30, 2019$60.15K–
Q1 FY2019Mar 31, 2019$15.98K–
Q4 FY2018Dec 31, 2018$0–
Q3 FY2018Sep 30, 2018$0–
Q2 FY2018Jun 30, 2018$0–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$0–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$0-100.0%
Q3 FY2016Sep 30, 2016$0–
Q2 FY2016Jun 30, 2016$0-100.0%
Q1 FY2016Mar 31, 2016$0-100.0%
Q4 FY2015Dec 31, 2015$2130.0%
Q1 FY2015Mar 31, 2015$0–
Q4 FY2014Dec 31, 2014$213–
Q3 FY2014Sep 30, 2014$213–
Q2 FY2014Jun 30, 2014$213–

More Panacea Life Sciences figures

See a number that looks wrong?